Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Rev. méd. Chile ; 145(2): 219-229, feb. 2017. ilus, tab
Article in Spanish | LILACS | ID: biblio-845527

ABSTRACT

HIV infection induces alterations in almost all immune cell populations, mainly in CD4+ T cells, leading to the development of opportunistic infections. The gut-associated lymphoid tissue (GALT) constitutes the most important site for viral replication, because the main target cells, memory T-cells, reside in this tissue. It is currently known that alterations in GALT are critical during the course of the infection, as HIV-1 induces loss of tissue integrity and promotes translocation of microbial products from the intestinal lumen to the systemic circulation, leading to a persistent immune activation state and immune exhaustion. Although antiretroviral treatment decreases viral load and substantially improves the prognosis of the infection, the alterations in GALT remains, having a great impact on the ability to establish effective immune responses. This emphasizes the importance of developing new therapeutic alternatives that may promote structural and functional integrity of this tissue. In this regard, therapy with probiotics/prebiotics has beneficial effects in GALT, mainly in syndromes characterized by intestinal dysbiosis, including the HIV-1 infection. In these patients, the consumption of probiotics/prebiotics decreased microbial products in plasma and CD4+ T cell activation, increased CD4+ T cell frequency, in particular Th17, and improved the intestinal flora. In this review, the most important findings on the potential impact of the probiotics/prebiotics therapy are discussed.


Subject(s)
Humans , HIV Infections/diet therapy , Probiotics/administration & dosage , Gastrointestinal Tract/virology , Prebiotics/administration & dosage , Lymphoid Tissue/virology , CD4-Positive T-Lymphocytes , Viral Load , Gastrointestinal Tract/metabolism , Lymphoid Tissue/metabolism
2.
Rev. argent. microbiol ; 48(2): 110-118, jun. 2016. graf, tab
Article in English | LILACS | ID: biblio-843156

ABSTRACT

High levels of circulating EBV load are used as a marker of post-transplant lymphoproliferative disorders (PTLD). There is no consensus regarding the threshold level indicative of an increase in peripheral EBV DNA. The aim of the study was to clinically validate a developed EBV quantification assay for early PTLD detection. Transversal study: paired peripheral blood mononuclear cells (PBMC), plasma and oropharyngeal lymphoid tissue (OLT) from children undergoing a solid organ transplant with (n = 58) and without (n = 47) PTLD. Retrospective follow-up: 71 paired PBMC and plasma from recipients with (n = 6) and without (n = 6) PTLD history. EBV load was determined by real-time PCR. The diagnostic ability to detect all PTLD (categories 1-4), advanced PTLD (categories 2-4) or neoplastic PTLD (categories 3 and 4) was estimated by analyzing the test performance at different cut-off values or with a load variation greater than 0.5 log units. The higher diagnostic performance for identifying all, advanced or neoplastic PTLD, was achieved with cut-off values of 1.08; 1.60 and 2.47 log EBV gEq/10(5) PBMC or 2.30; 2.60; 4.47 log gEq/10(5) OLT cells, respectively. EBV DNA detection in plasma showed high specificity but low (all categories) or high (advanced/neoplastic categories) sensitivity for PTLD identification. Diagnostic performance was greater when: (1) a load variation in PBMC or plasma was identified; (2) combining the measure of EBV load in PBMC and plasma. The best diagnostic ability to identify early PTLD stages was achieved by monitoring EBV load in PBMC and plasma simultaneously; an algorithm was proposed.


La carga alta del virus Epstein-Barr se utiliza como un marcador de desórdenes linfoproliferativos postrasplante (post-transplant lymphoproliferative disorders [PTLD]). El objetivo de este estudio fue validar clínicamente un ensayo de cuantificación del virus Epstein-Barr para la detección temprana de PTLD. Se efectuó un estudio transversal en el que se analizaron muestras pareadas de células mononucleares periféricas (CMP), de plasma y de tejido linfoide orofaríngeo de niños con trasplante de órgano sólido, con PTLD (n = 58) y sin PTLD (n = 47). En el seguimiento retrospectivo se incluyeron 71 muestras pareadas de CMP y de plasma de trasplantados, con PTLD (n = 6) y sin PTLD (n = 6). La carga viral se determinó por PCR en tiempo real. Se estimó la capacidad diagnóstica para detectar PTLD (categorías: todas vs. avanzadas vs. neoplásicas) analizando diferentes valores de corte o una variación de carga mayor de 0,5 logaritmos. El mayor desempeño diagnóstico para identificar todos los PTLD, los avanzados y los neoplásicos, se obtuvo con valores de corte de 1,08; 1,60 y 2,47 log copias/10(5) en CMP y de 2,30; 2,60 y 4,48 log copias/10(5) en células de tejido linfoide orofaríngeo, respectivamente. La detección del ADN del virus Epstein-Barr en el plasma mostró una especificidad alta, pero una sensibilidad baja (todas las categorías) o alta (categorías avanzadas o neoplásicas) para identificar PTLD. Se observó el desempeño diagnóstico más alto en las siguientes condiciones: 1) al identificar una variación de carga en CMP o en plasma; 2) combinando la medición de la carga viral en CMP y en plasma. La mejor capacidad diagnóstica para identificar las etapas tempranas de los PTLD se logró mediante el seguimiento simultáneo de la carga viral en CMP y en plasma; se propone un algoritmo.


Subject(s)
Child , Child, Preschool , Humans , Infant , Postoperative Complications/virology , Viremia/diagnosis , Heart Transplantation , Kidney Transplantation , Liver Transplantation , Herpesvirus 4, Human/isolation & purification , Epstein-Barr Virus Infections/virology , Lymphoproliferative Disorders/virology , Postoperative Complications/diagnosis , Postoperative Complications/etiology , DNA, Viral/blood , Leukocytes, Mononuclear/virology , Cross-Sectional Studies , Retrospective Studies , Follow-Up Studies , Immunocompromised Host , Viral Load , Epstein-Barr Virus Infections/diagnosis , Early Detection of Cancer , Real-Time Polymerase Chain Reaction , Lymphoid Tissue/virology , Lymphoma/diagnosis , Lymphoma/etiology , Lymphoma/virology , Lymphoproliferative Disorders/diagnosis , Lymphoproliferative Disorders/etiology
3.
Medical Sciences Journal of Islamic Azad University. 2009; 19 (2): 81-86
in Persian | IMEMR | ID: emr-102100

ABSTRACT

Influenza virus causes the cell death in animals and human beings. Cell death occurs in two manners as necrosis and apoptosis. In this study, the types of cell death in lymphoid tissues assessed in experimentally infected chickens with H9N2 avian influenza virus [A/chicken/Iran/772/2000]. In this experimental study, 20 SPF chickens aged 3 weeks were divided equally into two groups. The treatment group was infected with 0.2 ml of 1:10 dilution and 10[7.5] EID50 titer of the virus intra-nasally and the control group was treated with saline normal in the same volume. Lymphoid organs including spleen, thymus and bursa of fabricius were collected after 72 hours of treatment and tissue specimens were fixed in 10% buffered formalin. Microscopic sections with the thickness of 5-6 micron were stained by H and E method. Histopathological examination of lymphoid tissues of the experimental groups indicated necrosis, apoptosis and lymphoid depletionsin the treatment group. Apoptotic changes in the splenic tissues were significantly different between two groups [p<0.001]. There were no significant differences between two groups in terms of changes in the thymus and bursa of fabricius. However, Necrotic changes and lymphoid depletions in the splenic tissues, thymus and bursa of fabricius were significantly different between two groups [p<0.001]. This study indicates that H9N2 avian influenza virus is able to cause lymphoid tissue damages through induction of apoptosis and necrosis


Subject(s)
Animals , Influenza in Birds/mortality , Cell Death , Chickens/virology , Influenza in Birds/pathology , Lymphoid Tissue/virology , Apoptosis , Necrosis
4.
Journal of Veterinary Science ; : 75-85, 2002.
Article in English | WPRIM | ID: wpr-172832

ABSTRACT

Porcine reproductive and respiratory syndrome virus (PRRSV) RNA load in sera and tissues during acute phase of infection was evaluated using a PCR- based quantitative assay. More than 80% of infected pigs (21/25) showed the peak level of viral RNA concentrations in serum (up to 8.6 x 108 copies/ml) at day 5 postinfection (PI), and started to clear the virus from the systemic circulation thereafter. Regression analysis using the viral RNA concentrations in sera obtained from days 5 to 14 PI showed that the viral RNA was cleared at the rate of 0.37 log reduction in the number of PRRSV RNA copies per day. It was estimated to be day 27 PI when the viral RNA in the serum of infected pigs becomes undetectable. When correlation analysis was performed between the systemic clearance rate and viral RNA concentrations in tissues of 9 infected pigs obtained at day 14 PI, moderately strong negative correlation was observed in the thymus (r = - 0.62) and brain stem (r = - 0.48), suggesting the capability of host animal to clear PRRSV from the systemic circulation appears to be related to the viral activity in the thymus and brain stem.


Subject(s)
Animals , Female , Male , Brain Stem/virology , Eye/virology , Logistic Models , Lymphoid Tissue/virology , Porcine Reproductive and Respiratory Syndrome/blood , Porcine respiratory and reproductive syndrome virus/genetics , RNA, Viral/analysis , Reference Standards , Reverse Transcriptase Polymerase Chain Reaction , Swine/virology , Time Factors , Viral Load , Viremia/veterinary
5.
Journal of Korean Medical Science ; : 281-288, 1994.
Article in English | WPRIM | ID: wpr-162672

ABSTRACT

A high incidence of a T cell phenotype of sinonasal lymphomas in other Asian countries has been associated with a high incidence of Epstein Barr virus (EBV) infection. We analyzed 13 sinonasal and 18 Waldeyer's ring lymphomas for the prevalence of EBV encoded RNA (EBER) using a sensitive and specific in situ hybridization. In addition, we examined the relationship of histologic findings and immunophenotype as well as the location of the lymphomas to the presence of EBV. The EBER was detected in each of 12 sinonasal lymphomas with a T cell immunophenotype. One B cell sinonasal lymphoma was EBER negative. Four of 18 Waldeyer's ring lymphomas were positive for EBER, including two T cell lymphomas. Two of 16 B cell Waldeyer's ring lymphomas were EBER positive. Morphologically, 11 of 20 diffuse large cell lymphomas, 2 diffuse mixed small and large cell lymphomas, 2 of 4 immunoblastic lymphomas and 1 lymphoplasmacytic lymphoma were EBER positive. Four follicular large cell lymphomas were EBER negative. A characteristic angiocentric or angiodestructive pattern was found in most T cell lymphomas and EBER positive cases. These findings indicate that EBV infection is more strongly associated with the T cell immunophenotype, angiocentric pattern and sinonasal location of the lymphoma.


Subject(s)
Adult , Aged , Female , Humans , Male , B-Lymphocytes/immunology , Herpesviridae Infections/virology , Herpesvirus 4, Human/genetics , Immunophenotyping , In Situ Hybridization , Incidence , Lymphoid Tissue/virology , Lymphoma, Non-Hodgkin/epidemiology , Maxillary Neoplasms/epidemiology , Middle Aged , Nasopharyngeal Neoplasms/epidemiology , Nose Neoplasms/epidemiology , Prevalence , RNA, Viral/analysis , Survival Rate , T-Lymphocytes/immunology , Tonsillar Neoplasms/epidemiology , Tumor Virus Infections/virology
SELECTION OF CITATIONS
SEARCH DETAIL